Lista de obras -

A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis

artículo científico publicado en 2008

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.

artículo científico publicado en 2010

Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection.

artículo científico publicado en 2009

Blast phase of essential thrombocythemia: A single center study

artículo científico publicado en 2009

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations

artículo científico publicado en 2007

Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment

scientific article published on 19 August 2005

Familial Chronic Myeloproliferative Disorders: Clinical Phenotype and Evidence of Disease Anticipation

artículo científico publicado en 2007

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

artículo científico publicado en 2009

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

artículo científico publicado en 2005

Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas

article

Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.

artículo científico publicado en 2010

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

artículo científico publicado en 2010

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation

artículo científico publicado en 2007

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders

artículo científico publicado en 2006

Leukemic transformation of polycythemia vera: a single center study of 23 patients

artículo científico publicado en 2005

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia

scientific article published on 01 November 2004

Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up

scientific article published on 01 November 2006

Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman

artículo científico publicado en 2004

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

artículo científico publicado en 2006

Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.

artículo científico publicado en 2003

Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.

artículo científico publicado en 2007

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

artículo científico publicado en 2005

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

artículo científico publicado en 2008

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

artículo científico publicado en 2005

Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern Italy

scientific article published on 01 January 2007

Role of the molecular staging and response in the management of follicular lymphoma patients

scientific article published on 01 June 2006

Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires

artículo científico publicado en 2009

Validation of cytogenetic-based risk stratification in primary myelofibrosis.

artículo científico publicado en 2010

Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients.

artículo científico publicado en 2010

Lista de obras de

A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.

Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection.

Blast phase of essential thrombocythemia: A single center study

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations

Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment

Familial Chronic Myeloproliferative Disorders: Clinical Phenotype and Evidence of Disease Anticipation

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas

Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders

Leukemic transformation of polycythemia vera: a single center study of 23 patients

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia

Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up

Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.

Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern Italy

Role of the molecular staging and response in the management of follicular lymphoma patients

Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires

Validation of cytogenetic-based risk stratification in primary myelofibrosis.

Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients.